Immunophenotyping by Flow Cytometry CD11c Test is a sophisticated diagnostic procedure utilized to identify and quantify the presence of CD11c antigen on the surface of immune cells. This test is particularly significant in the study of immune system functions and in diagnosing various hematological disorders, including certain types of leukemia and lymphomas. The CD11c marker is primarily found on dendritic cells, which play a crucial role in the immune response by processing and presenting antigens to T cells.
By employing flow cytometry, a technology that analyzes the physical and chemical characteristics of particles in a fluid as it passes through at least one laser, the CD11c test provides detailed information about the cell populations in a sample. This method allows for the rapid and accurate characterization of cell types based on the specific markers they express, making it invaluable in clinical diagnostics and research.
At DNA Labs UAE, this test is offered for 480 AED. The facility is equipped with state-of-the-art technology to ensure precise and reliable results. Conducted by a team of skilled professionals, the CD11c test at DNA Labs UAE provides critical insights that aid in the diagnosis and monitoring of immune-related diseases, contributing to the development of targeted treatment strategies.
The "Immunophenotyping by Flow Cytometry CD123 Test" is a sophisticated diagnostic procedure utilized to identify and quantify the presence of the CD123 marker on cells, particularly in the context of hematological disorders. Flow cytometry, the technology underpinning this test, enables the rapid analysis of multiple physical and chemical characteristics of thousands of particles per second as they flow in a fluid stream through a beam of light. The CD123 antigen is a surface marker commonly associated with various blood-related cancers, including certain leukemias and myelodysplastic syndromes. Its detection and quantification are crucial for accurate diagnosis, prognosis, and monitoring of treatment efficacy in affected patients.
The test is performed at DNA Labs UAE, a leading diagnostic and research facility known for its state-of-the-art technologies and commitment to precision medicine. With a test cost of 480 AED, patients and healthcare providers can access this critical diagnostic tool to aid in the management of hematological malignancies. The price reflects the sophisticated nature of the technology and the expertise required to accurately interpret the results, contributing to a tailored and effective treatment plan for patients.
Immunophenotyping by Flow Cytometry CD13 Test is a specialized diagnostic procedure performed at DNA Labs UAE, designed to identify and quantify the presence of CD13 antigen on the surface of cells. This test plays a crucial role in the diagnosis and monitoring of various hematological disorders, including certain types of leukemia and myeloid disorders. By employing flow cytometry technology, this test offers precise and detailed information about the cell populations in a blood or bone marrow sample, specifically focusing on the CD13 marker, which is significant in the differentiation and function of cells. The cost of the Immunophenotyping by Flow Cytometry CD13 Test at DNA Labs UAE is 480 AED, making it a valuable and accessible tool for healthcare professionals in diagnosing and managing hematological diseases with accuracy and efficiency.
Immunophenotyping by Flow Cytometry using the CD138 test is a sophisticated diagnostic procedure available at DNA Labs UAE, priced at 480 AED. This test is pivotal in identifying and quantifying cells that express the CD138 surface marker, which is predominantly found on plasma cells. The CD138 marker is crucial in the diagnosis and monitoring of various hematological disorders, including multiple myeloma and other plasma cell dyscrasias.
Flow cytometry allows for the rapid analysis of thousands of cells in a sample, providing detailed information on cell populations, including their size, granularity, and the presence of specific surface markers like CD138. This makes the CD138 test an invaluable tool in the clinical setting for the precise characterization of immune cells, aiding in the accurate diagnosis, prognosis, and treatment planning for patients with related disorders. DNA Labs UAE, with its state-of-the-art facilities and expert technical staff, ensures high-quality and reliable testing services, making it a preferred choice for patients and healthcare providers seeking comprehensive immunophenotyping analysis.
Immunophenotyping by Flow Cytometry CD14 Test is a sophisticated diagnostic procedure utilized to analyze the expression of the CD14 molecule on the surface of cells, particularly monocytes and macrophages, in a blood or bone marrow sample. This test is pivotal in the study of immune system disorders, infections, and certain types of leukemia, where the presence and quantity of CD14-expressing cells can provide critical insights into the patient's health status and guide treatment decisions.
Flow cytometry, the technology behind this test, allows for the rapid and accurate identification of cell populations by their physical and chemical characteristics. The CD14 test is especially important in the context of diagnosing and monitoring diseases that affect the immune system, as CD14 plays a key role in the innate immune response and inflammation.
In the United Arab Emirates, this specific test is available at DNA Labs UAE, a reputable facility known for its state-of-the-art diagnostic services. The cost of the Immunophenotyping by Flow Cytometry CD14 Test at DNA Labs UAE is 480 AED. This price reflects the intricate technology and expertise required to conduct the test and analyze its results, ensuring patients receive accurate and actionable health information.
Immunophenotyping by Flow Cytometry CD15 Test is a sophisticated diagnostic procedure used to identify and analyze specific cell types within a mixed cell population based on the presence of the CD15 antigen. This test plays a crucial role in the diagnosis and monitoring of various diseases, particularly in the realm of hematology and oncology, including certain types of leukemia and lymphoma. The CD15 antigen is a marker often found on the surface of certain white blood cells, and its detection is pivotal in distinguishing between different types of hematological disorders.
The procedure involves the use of flow cytometry, a technology that allows for the detailed characterization of the physical and chemical properties of cells or particles as they flow in a fluid stream through a beam of light. The presence and intensity of fluorescence emitted by labeled antibodies bound to the CD15 antigen can be measured, providing valuable information about the cell population under investigation.
In the United Arab Emirates, this test is available at DNA Labs UAE, a leading laboratory known for its state-of-the-art facilities and commitment to providing accurate and timely diagnostic services. The cost of the Immunophenotyping by Flow Cytometry CD15 Test at DNA Labs UAE is 480 AED. This investment in your health allows for precise disease diagnosis, enabling healthcare providers to tailor treatment strategies more effectively to the individual patient's condition.
Immunophenotyping by Flow Cytometry CD19 Test is a sophisticated diagnostic procedure utilized to identify and quantify cells expressing the CD19 antigen, a critical marker found on the surface of B lymphocytes. This test plays a pivotal role in the diagnosis and monitoring of B-cell lymphomas, leukemias, and certain autoimmune diseases by providing detailed insights into the immune system's status.
Conducted at DNA Labs UAE, a state-of-the-art facility known for its precision and reliability, the CD19 test employs flow cytometry technology. This technique allows for the rapid analysis of thousands of cells in a sample, making it possible to not only detect the presence of CD19-positive cells but also to measure their proportion within the larger cell population.
The test cost is set at 480 AED, reflecting the intricate technology and expertise required to perform this analysis. Patients undergoing this test can expect a thorough evaluation of their B-cell population, which is crucial for accurate diagnosis and the formulation of an effective treatment plan. DNA Labs UAE ensures a seamless and efficient testing process, from sample collection to the delivery of results, making it a preferred choice for patients and healthcare providers alike.
The Immunophenotyping by Flow Cytometry CD1a Test is a specialized diagnostic procedure utilized to identify and classify various types of cells within a sample based on the presence of the CD1a molecule on their surface. This molecule is typically found on the surface of Langerhans cells, which are a type of dendritic cell playing a crucial role in the immune response by presenting antigens to T cells. The presence or absence of CD1a can aid in the diagnosis and classification of certain diseases, including various forms of leukemia and lymphoma, as well as other conditions involving the immune system.
Flow cytometry is the technology driving this test, offering a rapid and precise method to analyze thousands of cells in a short period. It works by passing cells in a fluid stream through a laser beam, where the cells are then analyzed based on the light scatter and the fluorescence emitted from fluorescently labeled antibodies that bind specifically to CD1a molecules.
In the UAE, this test is available at DNA Labs, a reputable laboratory known for its advanced diagnostic services. The cost of the Immunophenotyping by Flow Cytometry CD1a Test at DNA Labs UAE is 480 AED. This price reflects the sophisticated nature of the test and the valuable insights it provides in clinical diagnostics, particularly in immunology and hematology. Patients and healthcare providers looking to avail of this test can expect professional service and accurate results, contributing to informed clinical decisions and personalized treatment plans.
Immunophenotyping by Flow Cytometry CD2 Test is a sophisticated diagnostic tool used to analyze the expression of the CD2 surface marker on cells, primarily lymphocytes. This test is crucial in the diagnosis and monitoring of various hematological disorders and immune system diseases. CD2 is a protein found on the surface of T cells and natural killer (NK) cells, playing a significant role in cell adhesion and activation. By identifying the presence and quantity of cells expressing CD2, healthcare providers can gain valuable insights into a patient's immune status, aiding in the diagnosis of conditions such as lymphomas, leukemias, and certain autoimmune diseases.
The test is performed using flow cytometry, a powerful technology that allows for the detailed analysis of thousands of cells in a short period. During the procedure, a sample of the patient's blood or bone marrow is treated with fluorescent antibodies that specifically target the CD2 marker. As the sample passes through the flow cytometer, a laser excites the fluorescent dye, allowing for the detection and quantification of CD2-positive cells.
At DNA Labs UAE, the Immunophenotyping by Flow Cytometry CD2 Test is offered at a cost of 480 AED. DNA Labs UAE is equipped with state-of-the-art facilities and employs a team of highly skilled professionals to ensure accurate and reliable test results. The lab's commitment to quality and patient care makes it an excellent choice for individuals requiring this specialized test.
Immunophenotyping by Flow Cytometry CD20 Test is a specialized diagnostic procedure performed at DNA Labs UAE. Priced at 480 AED, this test plays a critical role in the identification and classification of various types of blood cell cancers, including lymphomas and leukemias. The CD20 marker, targeted in this test, is primarily found on the surface of B cells, a type of white blood cell crucial for the immune response. By using flow cytometry technology, the test accurately quantifies the presence of cells expressing the CD20 antigen, thereby aiding in the diagnosis, prognosis, and treatment planning for patients with certain hematological malignancies. This precise and targeted approach ensures that clinicians can develop more effective, individualized treatment strategies for affected patients.
